Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma

Overview of attention for article published in Journal of Neuro-Oncology, September 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 18,980 followers.

RT @JNeurooncol: Using data for 100pts, Patel et al @UCLA demonstrate SRS and fSRT are comparable options for tumor control in patients in…

14 Oct 2019

Reply Repost Favourite

RT @JNeurooncol: Using data for 100pts, Patel et al @UCLA demonstrate SRS and fSRT are comparable options for tumor control in patients in…

14 Oct 2019

Reply Repost Favourite

@UCLAHealth @UCLAHealthNews @dgsomucla #awesome

14 Oct 2019

Reply Repost Favourite

Using data for 100pts, Patel et al @UCLA demonstrate SRS and fSRT are comparable options for tumor control in patients in vestibular schwannomas and suggest a cochlear radiation threshold of 5 and 35Gy to preserve hearing after SRS and fSRT, respectively.

14 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.